481 related articles for article (PubMed ID: 6368883)
1. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
Kesäniemi YA; Grundy SM
JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
[TBL] [Abstract][Full Text] [Related]
2. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
Nye ER; Sutherland WH; Temple Wa
N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
[TBL] [Abstract][Full Text] [Related]
3. Clinical results with gemfibrozil.
Pickering JE
Am J Cardiol; 1983 Aug; 52(4):39B-40B. PubMed ID: 6351579
[No Abstract] [Full Text] [Related]
4. Treatment of type III hyperlipoproteinemia with four different treatment regimens.
Hoogwerf BJ; Bantle JP; Kuba K; Frantz ID; Hunninghake DB
Atherosclerosis; 1984; 51(2-3):251-9. PubMed ID: 6588975
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia.
Lewis JE
Angiology; 1982 Sep; 33(9):603-12. PubMed ID: 6957156
[TBL] [Abstract][Full Text] [Related]
6. Studies on hypoxic dyslipidaemia. Effect of lipid modulating drugs.
Mälkönen M; Muona M; Manninen V
Acta Med Scand Suppl; 1982; 668():130-5. PubMed ID: 6963088
[TBL] [Abstract][Full Text] [Related]
7. Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study.
Manninen V; Mälkönen M; Eisalo A; Virtamo J; Tuomilehto J; Kuusisto P
Acta Med Scand Suppl; 1982; 668():82-7. PubMed ID: 6762809
[No Abstract] [Full Text] [Related]
8. Nutritional & pharmacologic management of hyperlipoproteinemia.
Pickering JE
Angiology; 1982 Sep; 33(9):577-80. PubMed ID: 6957154
[TBL] [Abstract][Full Text] [Related]
9. Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins.
Vega GL; Grundy SM
JAMA; 1985 Apr; 253(16):2398-403. PubMed ID: 3856692
[TBL] [Abstract][Full Text] [Related]
10. Effect of gemfibrozil on serum lipids in man.
Fenderson RW; Deutsch S; Menachemi E; Chin B; Samuel P
Angiology; 1982 Sep; 33(9):581-93. PubMed ID: 6751166
[TBL] [Abstract][Full Text] [Related]
11. Gemfibrozil treatment: a comparison with clofibrate.
Howard AN; Ghosh P
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of gemfibrozil on lipoprotein metabolism.
Saku K; Gartside PS; Hynd BA; Kashyap ML
J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of the effect of Gemfibrozil on some haematological parameters.
O'Brien JR; Etherington MD; Shuttleworth RD; Adams CM; Middleton JE; Goodland FC
Thromb Res; 1982 May; 26(4):275-9. PubMed ID: 6955993
[TBL] [Abstract][Full Text] [Related]
14. Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy.
Kissebah AH; Alfarsi S; Adams PW; Seed M; Folkard J; Wynn V
Atherosclerosis; 1976; 24(1-2):199-218. PubMed ID: 182185
[TBL] [Abstract][Full Text] [Related]
15. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
Sirtori CR; Franceschini G; Gianfranceschi G; Sirtori M; Montanari G; Tremoli E; Maderna P; Colli S; Zoppi F
J Lab Clin Med; 1987 Sep; 110(3):279-86. PubMed ID: 3475394
[TBL] [Abstract][Full Text] [Related]
16. Change in composition of high density lipoprotein during gemfibrozil therapy.
Sorisky A; Ooi TC; Simo IE; Meuffels M; Hindmarsh JT; Nair R
Atherosclerosis; 1987 Oct; 67(2-3):181-9. PubMed ID: 3118893
[TBL] [Abstract][Full Text] [Related]
17. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
Weisweiler P; Schwandt P
Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of gemfibrozil and clofibrate in type III hyperlipoproteinemia.
Larsen ML; Illingworth DR; O'Malley JP
Atherosclerosis; 1994 Apr; 106(2):235-40. PubMed ID: 8060383
[TBL] [Abstract][Full Text] [Related]
19. Effects of fenofibrate, gemfibrozil and nicotinic acid on plasma lipoprotein levels in normal and hyperlipidemic mice. A proposed model for drug screening.
Olivier P; Plancke MO; Marzin D; Clavey V; Sauzieres J; Fruchart JC
Atherosclerosis; 1988 Mar; 70(1-2):107-14. PubMed ID: 3162679
[TBL] [Abstract][Full Text] [Related]
20. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
Nikkilä EA; Ylikahri R; Huttunen JK
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
